Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV-001: DWP-450 for Glabellar Lines
NCT02334423Phase 3Completed
- Sponsor
- Evolus, Inc.
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of prabotulinumtoxinA in glabellar lines, sponsored by Evolus, Inc.. Started Jan 2015; status: completed.
02
Drugs
prabotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02334423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334423.